Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Athanassios K Giarmoukakis, Styliani V Blazaki, Georgios C Bontzos, Argyro D Plaka, Konstantinos N Seliniotakis, Larissa D Ioannidi & Miltiadis K Tsilimbaris. (2020) Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema. Therapeutics and Clinical Risk Management 16, pages 1067-1074.
Read now
Read now
David Bellocq, Thibaud Mathis, Nicolas Voirin, Zainab Machkour Bentaleb, Rebecca Sallit, Philippe Denis & Laurent Kodjikian. (2019) Incidence of Irvine Gass Syndrome after Phacoemulsification with Spectral-Domain Optical Coherence Tomography. Ocular Immunology and Inflammation 27:8, pages 1224-1231.
Read now
Read now
Aniruddha Agarwal, Francesco Pichi, Alessandro Invernizzi & Vishali Gupta. (2019) Disease of the Year: Differential Diagnosis of Uveitic Macular Edema. Ocular Immunology and Inflammation 27:1, pages 72-88.
Read now
Read now
Giuseppe Giannaccare, Alessandro Finzi, Stefano Sebastiani, Fedele Greco, Piera Versura & Emilio C. Campos. (2018) The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery. Current Eye Research 43:12, pages 1445-1453.
Read now
Read now
Valentina Sarao, Daniele Veritti, Erica Maurutto, Nicolò Rassu, Enrico Borrelli, Anat Loewenstein, Srinivas Sadda & Paolo Lanzetta. (2018) Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery. Expert Opinion on Pharmacotherapy 19:14, pages 1551-1563.
Read now
Read now
Scott R. Peterson, Paolo A. Silva, Timothy J. Murtha & Jennifer K. Sun. (2018) Cataract Surgery in Patients with Diabetes: Management Strategies. Seminars in Ophthalmology 33:1, pages 75-82.
Read now
Read now
Bora Yüksel, Ömer Karti & Tuncay Kusbeci. (2017) Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives. Clinical Ophthalmology 11, pages 2183-2190.
Read now
Read now
Rishi P Singh, Giovanni Staurenghi, Ayala Pollack, Adeniyi Adewale, Thomas M Walker, Dana Sager & Robert Lehmann. (2017) Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies. Clinical Ophthalmology 11, pages 1021-1029.
Read now
Read now
Sunali Goyal, Joshua Hardin, Sami H. Uwaydat, Abdallah A. Ellabban, David B. Warner & Ahmed B Sallam. (2017) Review and update of cataract surgery in the diabetic eye. Expert Review of Ophthalmology 12:5, pages 359-371.
Read now
Read now
Jordana K Schmier, David W Covert, Carolyn K Hulme-Lowe, Anmol Mullins & Emmanuel M Mahlis. (2016) Treatment costs of cystoid macular edema among patients following cataract surgery. Clinical Ophthalmology 10, pages 477-483.
Read now
Read now
Andrzej Grzybowski, Bartosz L Sikorski, Francisco J Ascaso & Valentín Huerva. (2016) Pseudophakic cystoid macular edema: update 2016. Clinical Interventions in Aging 11, pages 1221-1229.
Read now
Read now
Francesco Semeraro, Andrea Russo, Elena Gambicorti, Sarah Duse, Francesco Morescalchi, Sara Vezzoli & Ciro Costagliola. (2015) Efficacy and vitreous levels of topical NSAIDs. Expert Opinion on Drug Delivery 12:11, pages 1767-1782.
Read now
Read now
Rajesh K Rajpal, Bryan Ross, Sachin D Rajpal & Khoa Hoang. (2014) Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence. Patient Preference and Adherence 8, pages 925-931.
Read now
Read now
Nour Maya N. Haddad, Jennifer K. Sun, Samer Abujaber, Deborah K. Schlossman & Paolo S. Silva. (2014) Cataract Surgery and its Complications in Diabetic Patients. Seminars in Ophthalmology 29:5-6, pages 329-337.
Read now
Read now
Moataz F Elsawy, Nermine Badawi & Hany A Khairy. (2013) Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery. Clinical Ophthalmology 7, pages 1245-1249.
Read now
Read now
Articles from other publishers (59)
Leo Ka Yu Chan, Sui Sum Lin, Fiona Chan & Danny Siu-Chun Ng. (2023) Optimizing treatment for diabetic macular edema during cataract surgery. Frontiers in Endocrinology 14.
Crossref
Crossref
Anđela Jukić, Rajka Kasalica Žužul, Josip Pavan, Mila Lovrić, Ana Kozmar, Davor Plavec, Tomislav Kuzman, Miro Kalauz & Tomislav Jukić. (2022) Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)—Randomized Controlled Trial. Medicina 58:11, pages 1667.
Crossref
Crossref
Shan-Shan Li, Hui-Hui Wang, Yan-Ling Wang, Da-Wei Zhang & Xi Chen. (2022) Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery. International Ophthalmology 43:1, pages 271-284.
Crossref
Crossref
Chu-Yu Yen, Ju-Chuan Yen, Chun-Chen Chen, Hsiao-Yun Hu, Feng-Shiang Cheng & Po-Chen Tseng. (2022) Therapeutic effect of cataract surgery with simultaneous intravitreal injection of aflibercept on diabetic macular edema: An observational study. Medicine 101:33, pages e30115.
Crossref
Crossref
Assaf Ben-Arzi, Rita Ehrlich & Ron Neumann. (2022) Retinal Diseases: The Next Frontier in Pharmacodelivery. Pharmaceutics 14:5, pages 904.
Crossref
Crossref
Chia-An Hsu, Sheng-Chu Chi & Yu-Bai Chou. (2022) Comparison of Efficacy between Non-Steroidal Anti-Inflammatory Drugs and Anti-Vascular Endothelial Growth Factor in Preventing Macular Edema after Cataract Surgery in Diabetic Patients. Journal of Personalized Medicine 12:3, pages 351.
Crossref
Crossref
Jennifer Hind, Aaron Jamison, Stefano Schipani, Julie Connolly, Paul Cauchi & Vikas Chadha. (2022) Outcomes of cataract surgery in patients previously treated with orbital radiotherapy. Journal of Cataract and Refractive Surgery 48:2, pages 162-167.
Crossref
Crossref
Jonathan A. Go, Christina A. Mamalis & Sumitra S. Khandelwal. (2021) Cataract Surgery Considerations for Diabetic Patients. Current Diabetes Reports 21:12.
Crossref
Crossref
Selim Cevher & Gülçin Aydoğdu. (2020) How does nepafenac affect the choroidal thickness after uneventful cataract surgery?. European Journal of Ophthalmology 31:5, pages 2319-2328.
Crossref
Crossref
Nisa Silva, André Ferreira, João Heitor Marques, Natália Ferreira, Nuno Correia, Bernardete Pessoa, João Melo Beirão, Ferenc Kuhn & Angelina Meireles. (2021) Epiretinal membrane vitrectomy: outcomes with or without cataract surgery and a novel prognostic factor for cystoid macular edema. Graefe's Archive for Clinical and Experimental Ophthalmology 259:7, pages 1731-1740.
Crossref
Crossref
Behrad Samadi, Mats Lundstrom, Madeleine Zetterberg, Ingela Nilsson, Per Montan, Anders Behndig & Maria Kugelberg. (2021) Anti-inflammatory treatment after cataract surgery in Sweden: changes in prescribing patterns from 2010 to 2017. BMJ Open Ophthalmology 6:1, pages e000635.
Crossref
Crossref
Carlo Cagini, Alessio Cerquaglia, Adriana Pellegrino, Alessia Iannone, Marco Lupidi & Tito Fiore. (2020) Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects. Acta Ophthalmologica 99:1.
Crossref
Crossref
冬 李. (2021) Effect of Phacoemulsification on Macular Area Ultrastructure of Age-Related Cataract Patients. Hans Journal of Ophthalmology 10:02, pages 25-32.
Crossref
Crossref
Tushar Kumar, Mohan Lal Pandey, Kritika Gogia, Rishabh Rathi, Astha Patel & Srujathi Muthamsetty. (2020) A Prospective Interventional Study to Evaluate the Efficacy of Nepafenac 0.1% for Prevention of Macular Oedema Associated with Cataract Surgery in Patients with Diabetes. Journal of Evolution of Medical and Dental Sciences 9:04, pages 231-235.
Crossref
Crossref
David Liao & David Boyer. 2020. Posterior Segment Complications of Cataract Surgery. Posterior Segment Complications of Cataract Surgery
125
137
.
Andrzej Grzybowski & Piotr Kanclerz. 2020. Current Concepts in Ophthalmology. Current Concepts in Ophthalmology
55
97
.
Thais F. Conti & Rishi P. Singh. (2019) Advancing Insights Into Diabetic Eye Disease: 5th Annual American Society of Retina Specialists Presidents’ Young Investigator Award Lecture. Journal of VitreoRetinal Diseases 3:5, pages 384-389.
Crossref
Crossref
Reeta Danni, Antti Viljanen, Alexander Aaronson & Raimo Tuuminen. (2019) Preoperative anti‐inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac. Acta Ophthalmologica 97:6, pages 589-595.
Crossref
Crossref
Shahenda A El Gharbawy, Essam A Darwish, Khaled G Abu Eleinen & Moataz Hamed Osman. (2018) Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes. European Journal of Ophthalmology 29:4, pages 453-457.
Crossref
Crossref
Ahmed Alnagdy, Ahmed M. Eissa & Amr El-Kannishy. 2019. Frontiers in Ophthalmology and Ocular Imaging. Frontiers in Ophthalmology and Ocular Imaging.
Sophie Bryde Laursen, Jesper Hφiberg Erichsen, Lars Morten Holm & Line Kessel. (2019) Prevention of macular edema in patients with diabetes after cataract surgery. Journal of Cataract and Refractive Surgery 45:6, pages 854-869.
Crossref
Crossref
Andrzej Grzybowski, Piotr Kanclerz, Valentín Huerva, Francisco J. Ascaso & Raimo Tuuminen. (2019) Diabetes and Phacoemulsification Cataract Surgery: Difficulties, Risks and Potential Complications. Journal of Clinical Medicine 8:5, pages 716.
Crossref
Crossref
Jina V. Han, Dipika V. Patel, David Squirrell & Charles NJ. McGhee. (2019) Cystoid macular oedema following cataract surgery: A review. Clinical & Experimental Ophthalmology 47:3, pages 346-356.
Crossref
Crossref
Hasan Kiziltoprak, Kemal Tekin, Merve Inanc & Yasin Sakir Goker. (2019) Cataract in diabetes mellitus. World Journal of Diabetes 10:3, pages 140-153.
Crossref
Crossref
John Hovanesian & Edward Holland. (2019) Tolerability and toxicity of topically applied nepafenac 0.3% compared with generic ketorolac 0.5%. Journal of Cataract and Refractive Surgery 45:2, pages 174-180.
Crossref
Crossref
Reeta Danni, Claudia Taipale, Lotta Ilveskoski & Raimo Tuuminen. (2019) Diabetes Alone Does Not Impair Recovery From Uneventful Cataract Surgery. American Journal of Ophthalmology 198, pages 37-44.
Crossref
Crossref
M. A. Frolov, D. V. Lipatov, I. A. Bashina, A. M. Frolov & E. S. Belyaeva. (2019) Immunological Aspects of Macular Edema after Cataract Surgery in Patients with Diabetes Mellitus. Ophthalmology in Russia 15:4, pages 463-469.
Crossref
Crossref
Francesco Bandello, Rosangela Lattanzio, Ilaria Zucchiatti, Alessandro Arrigo, Marco Battista & Maria Vittoria Cicinelli. 2019. Clinical Strategies in the Management of Diabetic Retinopathy. Clinical Strategies in the Management of Diabetic Retinopathy
97
183
.
Petteri Ylinen, Claudia Taipale, Juha-Matti Lindholm, Ilkka Laine, Emil Holmström & Raimo Tuuminen. (2018) Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared. Acta Ophthalmologica 96:8, pages 853-859.
Crossref
Crossref
Petteri Ylinen, Emil Holmström, Ilkka Laine, Juha-Matti Lindholm & Raimo Tuuminen. (2018) Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination. Acta Ophthalmologica 96:5, pages 486-493.
Crossref
Crossref
Efrat FleissigShai Cohen, Matias IglickiMichaella GoldsteinDinah Zur. (2018) CHANGES IN CHOROIDAL THICKNESS IN CLINICALLY SIGNIFICANT PSEUDOPHAKIC CYSTOID MACULAR EDEMA. Retina 38:8, pages 1629-1635.
Crossref
Crossref
Patrick Murtagh, Richard Comer & Gerry Fahy. (2018) Corneal perforation in undiagnosed Sjögren’s syndrome following topical NSAID and steroid drops post routine cataract extraction. BMJ Case Reports, pages bcr-2018-225428.
Crossref
Crossref
Hassan Hamoudi, Ulrik Correll Christensen & Morten La Cour. (2018) Epiretinal membrane surgery: an analysis of 2-step sequential- or combined phacovitrectomy surgery on refraction and macular anatomy in a prospective trial. Acta Ophthalmologica 96:3, pages 243-250.
Crossref
Crossref
Dong H. Yoon, Dong J. Kang, Myung J. Kim & Hong K. Kim. (2018) New observation of microcystic macular edema as a mild form of cystoid macular lesions after standard phacoemulsification. Medicine 97:15, pages e0355.
Crossref
Crossref
Hadi Kjærbo. (2018) Nepafenac in the Treatment of Ocular Inflammation Following Cataract Surgery (Pseudophakic Macular Oedema) – an Update. European Ophthalmic Review 12:1, pages 32.
Crossref
Crossref
Hassan Hamoudi. (2018) Epiretinal membrane surgery: an analysis of sequential or combined surgery on refraction, macular anatomy and corneal endothelium. Acta Ophthalmologica 96, pages 1-24.
Crossref
Crossref
Bobeck S. Modjtahedi & Donald S. Fong. (2018) Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785). Ophthalmology 125:1, pages e10-e11.
Crossref
Crossref
Irina A. Bashina, Michael A. Frolov & Dmitriy V. Lipatov. (2017) Prevention of macular oedema after cataract surgery in patients with diabetes mellitus. Diabetes mellitus 20:5, pages 350-355.
Crossref
Crossref
K Oyewole, F Tsogkas, M Westcott & S Patra. (2017) Benchmarking cataract surgery outcomes in an ethnically diverse and diabetic population: final post-operative visual acuity and rates of post-operative cystoid macular oedema. Eye 31:12, pages 1672-1677.
Crossref
Crossref
William Trattler & Kamran Hosseini. (2017) Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study. Ophthalmology and Therapy 6:2, pages 277-284.
Crossref
Crossref
Viral V Juthani, Elizabeth Clearfield & Roy S Chuck. (2017) Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Crossref
Rishi P. Singh, Robert Lehmann, Joseph Martel, Kevin Jong, Ayala Pollack, Alexis Tsorbatzoglou, Giovanni Staurenghi, Guadalupe Cervantes-Coste Cervantes, Louis Alpern, Satish Modi, Liza Svoboda, Adeniyi Adewale & Glenn J. Jaffe. (2017) Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy. Ophthalmology 124:6, pages 776-785.
Crossref
Crossref
Bobeck S. Modjtahedi, John F. Paschal, Michael Batech, Tiffany Q. Luong & Donald S. Fong. (2017) Reply. American Journal of Ophthalmology 177, pages 238-239.
Crossref
Crossref
Andrzej Grzybowski & Joanna Adamiec-Mroczek. (2017) Perioperative Topical Nonsteroidal Anti-inflammatory Drugs for Macular Edema Prophylaxis Following Cataract Surgery. American Journal of Ophthalmology 177, pages 237-238.
Crossref
Crossref
Ayala Pollack, Giovanni Staurenghi, Dana Sager, Bickol Mukesh, Harvey Reiser & Rishi P Singh. (2017) Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy. British Journal of Ophthalmology 101:4, pages 423-427.
Crossref
Crossref
Bobeck S. Modjtahedi, John F. Paschal, Michael Batech, Tiffany Q. Luong & Donald S. Fong. (2017) Perioperative Topical Nonsteroidal Anti-inflammatory Drugs for Macular Edema Prophylaxis Following Cataract Surgery. American Journal of Ophthalmology 176, pages 174-182.
Crossref
Crossref
Morteza Entezari, Alireza Ramezani, Homayon Nikkhah & Mehdi Yaseri. (2016) The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial. International Ophthalmology 37:1, pages 13-18.
Crossref
Crossref
Francesco Boscia, Ermete Giancipoli, Giuseppe D’Amico Ricci & Antonio Pinna. (2017) Management of macular oedema in diabetic patients undergoing cataract surgery. Current Opinion in Ophthalmology 28:1, pages 23-28.
Crossref
Crossref
Blanche X Lim, Chris HL Lim, Dawn K Lim, Jennifer R Evans, Catey Bunce & Richard Wormald. (2016) Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Angela P. Bessette, Seenu M. Hariprasad & Rishi P. Singh. (2016) The Role of NSAIDs in the Management of Macular Edema. Ophthalmic Surgery, Lasers and Imaging Retina 47:8, pages 704-707.
Crossref
Crossref
James E. Chastain, Mark E. Sanders, Michael A. Curtis, Nagendra V. Chemuturi, Martha E. Gadd, Michael A. Kapin, Kerry L. Markwardt & David C. Dahlin. (2016) Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye. Experimental Eye Research 145, pages 58-67.
Crossref
Crossref
Colin J. Chu, Robert L. Johnston, Charlotte Buscombe, Ahmed B. Sallam, Queresh Mohamed & Yit C. Yang. (2016) Risk Factors and Incidence of Macular Edema after Cataract Surgery. Ophthalmology 123:2, pages 316-323.
Crossref
Crossref
Stephen J. Kim, Scott D. Schoenberger, Jennifer E. Thorne, Justis P. Ehlers, Steven Yeh & Sophie J. Bakri. (2015) Topical Nonsteroidal Anti-inflammatory Drugs and Cataract Surgery. Ophthalmology 122:11, pages 2159-2168.
Crossref
Crossref
Laura H.P. Wielders, Verena A. Lambermont, Jan S.A.G. Schouten, Frank J.H.M. van den Biggelaar, Gill Worthy, Rob W.P. Simons, Bjorn Winkens & Rudy M.M.A. Nuijts. (2015) Prevention of Cystoid Macular Edema After Cataract Surgery in Nondiabetic and Diabetic Patients: A Systematic Review and Meta-Analysis. American Journal of Ophthalmology 160:5, pages 968-981.e33.
Crossref
Crossref
Scott M. Friedman, Talat H. Almukhtar, Carl W. Baker, Adam R. Glassman, Michael J. Elman, Neil M. Bressler, Manvi P. Maker, Lee M. Jampol & Michele Melia. (2015) TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL DIABETIC MACULAR EDEMA. Retina 35:5, pages 944-956.
Crossref
Crossref
Ramin Nourinia. (2015) State of the art management of diabetic macular edema. World Journal of Ophthalmology 5:2, pages 55.
Crossref
Crossref
Francesco Bandello, Ilaria Zucchiatti, Rosangela Lattanzio & Chiara Preziosa. 2014. Clinical Strategies in the Management of Diabetic Retinopathy. Clinical Strategies in the Management of Diabetic Retinopathy
65
121
.
Marina Borisovna Ro, Sergey Aleksandrovich Ignatyev, Igor Borisovich Alekseyev & Yelena Aleksandrovna Korchuganova. (2013) Successful treatment of the Irvine-Gass syndrome with Nevanac. Ophthalmology Reports 6:4, pages 69-72.
Crossref
Crossref
Afshin ShafieeLyle M. BowmanEddie HouKamran Hosseini. (2013) Aqueous Humor Penetration of Ketorolac Formulated in DuraSite or DuraSite 2 Delivery Systems Compared to Acular LS in Rabbits. Journal of Ocular Pharmacology and Therapeutics 29:9, pages 812-816.
Crossref
Crossref